My Blog

Eli Lilly is a recession-resistant stock with major growth potential

Traders work beneath monitors displaying Eli Lilly signage on the floor of the New York Stock Exchange.

Michael Nagle | Bloomberg | Getty Images

The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week.

Related posts

World is ‘driven by envy,’ not ‘greed’


David Einhorn says he likes companies with big buybacks, unveils a Twitter bet


Doctors are concerned for Queen Elizabeth’s health, Buckingham Palace says


Leave a Comment